The Safety and Efficacy of Recombinant Human Prolactin
NCT00438490
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Recombinant Human Prolactin
Sponsor
Massachusetts General Hospital